SOX2 and colorectal cancer: All in all, although in vivo experiments are needed, this study reveals a novel FENDRR/Sox2 axis necessary for the CSC-like traits and chemoresistance of colorectal cancer cells, which might be a novel biomarker for colorectal cancer and chemotherapeutic efficiency.